EUVIMEDEUVIMED entdecken
Crossref

Inoculum effect of cefiderocol against NDM-1 producing Escherichia coli in vitro and in a murine model of peritonitis

Anne-Sophie Godron, Ariane Amoura, Claire Pistien, André Birgy, Sophie Magreault, Agnès B Jousset, Vincent Jullien, Agnès Lefort, Bruno Fantin, Imane El Meouche, Victoire de Lastours iD

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkae368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Anne-Sophie Godron und 10 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Université Sorbonne Paris Nord, Inserm, IAME, Paris 75018, France. Hauptthemen laut MEDLINE: Peritonitis, beta-Lactamases, Escherichia coli, Cephalosporins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: IAME, Fondation pour la Recherche Médicale, Agence Nationale de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cefiderocol is a siderophore cephalosporin active in vitro against carbapenemase-producing Enterobacterales, including New Delhi metallo-β-lactamases (NDM-1). A significant impact of the size of bacterial inoculum on its efficacy has been described in vitro, the clinical impact of which is unclear. Here, we analyse the inoculum effect of cefiderocol against E. coli-NDM-1 in vitro and in a murine peritonitis model. Materials and Methods Escherichia coli 62-pTOPO and its isogenic variant expressing NDM-1, 62-pTOPO-NDM, were constructed from a clinical strain. MICs and bactericidal kinetics were determined at standard (105 cfu/mL) and high inoculum (107 cfu/mL). The in vivo effect was assessed in a severe murine peritonitis model, comparing low (106 cfu/mL) and high (108 cfu/mL) inoculum. Survival rates, organ sterilization and bacterial counts in spleen and peritoneal fluid were compared.

Results

Cefiderocol MICs for 62-pTOPO and 62-pTOPO-NDM at standard and high inoculum were 0.008, 2, 2 and 1024 mg/L, respectively. Bactericidal activity was not achieved in vitro for 62-pTOPO-NDM at high inoculum with high cefiderocol concentrations (16 mg/L). In vivo, for 62-pTOPO-NDM, no difference was found in survival, organ sterilization or bacterial counts between low and high inoculum. For 62-pTOPO, no difference was observed in survival, despite less organ sterilization and higher bacterial counts in organs with the high inoculum.

Conclusion

A significant inoculum effect of cefiderocol was observed in vitro for 62-pTOPO and 62-pTOPO-NDM. However, the effectiveness of cefiderocol was not reduced in vivo with a high bacterial inoculum. In vitro inoculum effect of cefiderocol may not be clinically significant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritonitisbeta-LactamasesEscherichia coliCephalosporinsEscherichia coli InfectionsMicrobial Sensitivity TestsDisease Models, AnimalCefiderocolAnti-Bacterial AgentsAnimalsMiceFemaleBacterial LoadSurvival AnalysisSpleen

Substanzen

beta-Lactamasesbeta-lactamase NDM-1CephalosporinsCefiderocolAnti-Bacterial Agents

Autor:innen und Institutionen

  • Université Paris Cité, Université Sorbonne Paris Nord, Inserm, IAME, Paris 75018, France.
  • Université Paris Cité, Hôpital Robert Debré, AP-HP, Service de microbiologie, Paris F-75019France.
  • Université Sorbonne Paris Nord, Service de pharmacologie, Hôpital Avicenne, AP-HP, Bobigny F-93000, France.
  • Université Paris-Saclay, Service de bactériologie-hygiène and French National Reference Center for Antibiotic Resistance, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre F-94275, France.
  • Université Paris Cité, Service de Médecine Interne, Hôpital Beaujon, AP-HP, Clichy F-92210, France.

ORCID-Profile: Victoire de Lastours

Förderung

  • IAME
  • Fondation pour la Recherche Médicale
  • Agence Nationale de la Recherche

Zitieren

APA

Godron, A. S., Amoura, A., Pistien, C., Birgy, A., Magreault, S., Jousset, A. B., Jullien, V., Lefort, A., Fantin, B., El Meouche, I., & de Lastours, V. (2024). Inoculum effect of cefiderocol against NDM-1 producing Escherichia coli in vitro and in a murine model of peritonitis. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae368

Vancouver

Godron AS, Amoura A, Pistien C, Birgy A, Magreault S, Jousset AB, et al. Inoculum effect of cefiderocol against NDM-1 producing Escherichia coli in vitro and in a murine model of peritonitis. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae368

BibTeX
@article{Godron2024,
  author = {Godron, Anne-Sophie and Amoura, Ariane and Pistien, Claire and Birgy, André and Magreault, Sophie and Jousset, Agnès B and Jullien, Vincent and Lefort, Agnès and Fantin, Bruno and El Meouche, Imane and de Lastours, Victoire},
  title = {Inoculum effect of cefiderocol against NDM-1 producing Escherichia coli in vitro and in a murine model of peritonitis},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkae368}
}
Kostenlos starten →